AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Intaglip M OD 1000mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Intaglip M OD 1000mg/50mg Tablet

Combipack Metformin/Glimepiride 1000mg/50mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Prescribed independently or alongside other antidiabetic agents, optimal efficacy is achieved through adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concomitant medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels significantly reduces future health risks. Continued commitment to the prescribed diet and exercise regimen is crucial for successful diabetes management, as lifestyle significantly influences disease control. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its symptoms and management. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before initiating therapy. Potential drug interactions necessitate complete disclosure of all medications to your doctor to ensure treatment safety. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Intaglip M OD 1000mg/50mg Tablet

No text was provided to rewrite.

Uses of Intaglip M OD 1000mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Intaglip M OD 1000mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Intaglip M OD 1000mg/50mg tablets should be administered with a meal.

Common Side effects of Intaglip M OD 1000mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Intaglip M OD 1000mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Intaglip M OD 1000mg/50mg Tablet should be administered with a meal.

How Intaglip M OD 1000mg/50mg Tablet works:

One thousand milligram/fifty milligram InTaglip M tablets, taken once daily, combine two distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Intaglip M OD 1000mg/50mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Intaglip M OD 1000mg/50mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Intaglip M OD 1000mg/50mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Intaglip M OD 1000mg/50mg tablets cautiously. Dosage modification for Intaglip M OD 1000mg/50mg tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Intaglip M OD 1000mg/50mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Intaglip M OD 1000mg/50mg Tablet :

Should you forget to take your Intaglip M OD 1000mg/50mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.

Facts to Know About Intaglip M OD 1000mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Intaglip M OD 1000mg/50mg Tablet

Intaglip M OD 1000mg/50mg Tablets rarely cause hypoglycemia by themselves, but this can happen if you don't consume enough calories. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medication. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Intaglip M 1000mg/50mg tablets may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's advice.
Intaglip M OD 1000mg/50mg Tablets are contraindicated in patients allergic to any ingredient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Intaglip M OD 1000mg/50mg tablets combine metformin (a biguanide) and vildagliptin, both used to treat diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Intaglip M OD 1000mg/50mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue use and seek immediate medical attention.
Prolonged use of Intaglip M OD 1000mg/50mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Intaglip M OD 1000mg/50mg Tablets are safe when used as directed by your doctor. However, even with correct dosage, common side effects may include nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially with insulin or sulphonylurea use). Report any persistent side effects to your physician.
Intaglip M OD 1000mg/50mg...
86
MRP 100
13% off